Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Leukemia|October 23, 2009
JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survivalA Tefferi, T L Lasho, M M Patnaik, et al.
Bone Marrow Transplantation|October 30, 2012
Impact of lymphocyte and monocyte recovery on the outcomes of allogeneic hematopoietic SCT with fludarabine and melphalan conditioningL J DeCook, M Thoma, T Huneke, et al.
Leukemia Research|January 13, 2006
FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literatureA Pardanani, R P Ketterling, C-Y Li, et al.
Blood Cancer Journal|April 1, 2017
Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patientsL Saeed, M M Patnaik, K H Begna, et al.
European Journal of Internal Medicine|March 14, 2016
Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort studyJ Perez Botero, W D Ormsby, A A Ashrani, et al.
Blood Cancer Journal|January 3, 2015
Chronic myelomonocytic leukemia in younger patients: molecular and cytogenetic predictors of survival and treatment outcomeM M Patnaik, E A Wassie, E Padron, et al.
Leukemia|May 21, 2010
WHO-defined 'myelodysplastic syndrome with isolated del(5q)' in 88 consecutive patients: survival data, leukemic transformation rates and prevalence of JAK2, MPL and IDH mutationsM M Patnaik, T L Lasho, C M Finke, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 10, 2015
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patientsD J Wojenski, G T Bartoo, J A Merten, et al.
Leukemia|March 28, 2013
Mayo prognostic model for WHO-defined chronic myelomonocytic leukemia: ASXL1 and spliceosome component mutations and outcomesM M Patnaik, E Padron, R R LaBorde, et al.
Bone Marrow Transplantation|April 23, 2013
Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral centerA Dispenzieri, K Seenithamby, M Q Lacy, et al.
Pageof 3